
LINK . SPRINGER . COM {
}
Title:
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo | Cancer Immunology, Immunotherapy
Description:
Cyclin A1 is a promising antigen for T cell therapy being selectively expressed in high-grade ovarian cancer (OC) and acute myeloid leukemia (AML) stem cells. For adoptive T cell therapy, a single epitope has to be selected, with high affinity to MHC class I and adequate processing and presentation by malignant cells to trigger full activation of specific T cells. In silico prediction with three algorithms indicated 13 peptides of Cyclin A1 9 to 11 amino acids of length to have high affinity to HLA-A*02:01. Ten of them proved to be affine in an HLA stabilization assay using TAP-deficient T2 cells. Their immunogenicity was assessed by repetitive stimulation of CD8+ T cells from two healthy donors with single-peptide-pulsed dendritic cells or monocytes. Intracellular cytokine staining quantified the enrichment of peptide-specific functional T cells. Seven peptides were immunogenic, three of them against both donors. Specific cell lines were cloned and used in killing assays to demonstrate recognition of endogenous Cyclin A1 in the HLA-A*02:01-positive AML cell line THP-1. Immunopeptidome analysis based on direct isolation of HLA-presented peptides by mass spectrometry of primary AML and OC samples identified four naturally presented epitopes of Cyclin A1. The immunopeptidome of HeLa cells transfected with Cyclin A1 and HLA-A*02:01 revealed six Cyclin A1-derived HLA ligands. Epitope p410–420 showed high affinity to HLA-A*02:01 and immunogenicity in both donors. It proved to be naturally presented on primary AML blast and provoked spontaneous functional response of T cells from treatment naïve OC and, therefore, warrants further development for clinical application.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Telecommunications
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We find it hard to spot revenue streams.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.
Keywords {🔍}
cell, cells, cyclin, article, pubmed, peptides, peptide, google, scholar, specific, cas, cancer, epitope, epitopes, hla, hlaa, target, central, analysis, antigen, affinity, mhc, presentation, lines, thp, tcr, vitro, therapy, stimulation, ligandome, immunotherapy, hlaarestricted, class, ctl, processing, data, leukemia, donors, selection, performed, control, fig, high, prediction, assay, immunogenicity, respective, pbmc, responses, presented,
Topics {✒️}
ny-eso-1-reactive t-cell receptor carboxyfluorescein-diacetat-succinimidyl-ester 10 µm cd4 rpa-t4-apc-h7 single-peptide-pulsed autologous derndritic cells gene-modified human t-cells article download pdf juliane sarah walz dimethyldodecylamineoxide-succinimidyl-ester 5 µm peptide-pulsed plastic-adherent fraction ratio}}_{{{\mathrm{effector}}}} }}{{{\mathrm{ full size image endogenous immunoglobulin-derived neoepitopes single-peptide-pulsed dendritic cells pd-1/pd-l1 blockade immunotherapy single-peptide-pulsed autologous cells high-grade ovarian cancer mart-1-peptide elagigiltv served individual peptide side-chains hla-a2-restricted hepatitis cyclin a1-derived hla identify cyclin a1-derived cyclin a1-derived peptides stained cd3 sk7-percp ratio}}_{{{\mathrm{norm}}}} }}} biochemical large-scale identification t-cell-based immunotherapy tnfα mab11-pe-cy7 acute myeloid leukemia 1 μg/ml β2-microglobulin peptide-specific lytic activity web server issue immatics biotechnologies gmbh high-affinity taa-specific tcr cytokine-naïve thp-1 cells flow cytometry-based assay translational scientists working showing specific killing alphabeta tcr-mediated recognition specifically lysed apc acquired funding original online version tap-deficient t2 cells peptide-pulsed t2 cells german cancer consortium cytokine-positive cd8+ lymphocytes treatment-naïve oc patients cancer testis antigen cancer-testis antigen acute lymphoblastic leukemia full access
Schema {🗺️}
WebPage:
mainEntity:
headline:Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
description:Cyclin A1 is a promising antigen for T cell therapy being selectively expressed in high-grade ovarian cancer (OC) and acute myeloid leukemia (AML) stem cells. For adoptive T cell therapy, a single epitope has to be selected, with high affinity to MHC class I and adequate processing and presentation by malignant cells to trigger full activation of specific T cells. In silico prediction with three algorithms indicated 13 peptides of Cyclin A1 9 to 11 amino acids of length to have high affinity to HLA-A*02:01. Ten of them proved to be affine in an HLA stabilization assay using TAP-deficient T2 cells. Their immunogenicity was assessed by repetitive stimulation of CD8+ T cells from two healthy donors with single-peptide-pulsed dendritic cells or monocytes. Intracellular cytokine staining quantified the enrichment of peptide-specific functional T cells. Seven peptides were immunogenic, three of them against both donors. Specific cell lines were cloned and used in killing assays to demonstrate recognition of endogenous Cyclin A1 in the HLA-A*02:01-positive AML cell line THP-1. Immunopeptidome analysis based on direct isolation of HLA-presented peptides by mass spectrometry of primary AML and OC samples identified four naturally presented epitopes of Cyclin A1. The immunopeptidome of HeLa cells transfected with Cyclin A1 and HLA-A*02:01 revealed six Cyclin A1-derived HLA ligands. Epitope p410–420 showed high affinity to HLA-A*02:01 and immunogenicity in both donors. It proved to be naturally presented on primary AML blast and provoked spontaneous functional response of T cells from treatment naïve OC and, therefore, warrants further development for clinical application.
datePublished:2020-03-10T00:00:00Z
dateModified:2021-06-25T00:00:00Z
pageStart:1217
pageEnd:1227
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00262-020-02519-6
keywords:
Cyclin A1
Epitope
CD8 T cell
HLA immunopeptidome
Acute myeloid leukemia
Ovarian carcinoma
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig3_HTML.png
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:69
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Anja Tatjana Teck
url:http://orcid.org/0000-0002-9563-0341
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
type:Person
name:Sabrina Urban
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
type:Person
name:Petra Quass
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Annika Nelde
affiliation:
name:University of Tübingen
address:
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:University Hospital Tübingen
address:
name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:Heiko Schuster
affiliation:
name:University of Tübingen
address:
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:Immatics Biotechnologies GmbH
address:
name:Immatics Biotechnologies GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:Anne Letsch
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Antonia Busse
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Juliane Sarah Walz
affiliation:
name:University of Tübingen
address:
name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Ulrich Keilholz
affiliation:
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Sebastian Ochsenreither
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
description:Cyclin A1 is a promising antigen for T cell therapy being selectively expressed in high-grade ovarian cancer (OC) and acute myeloid leukemia (AML) stem cells. For adoptive T cell therapy, a single epitope has to be selected, with high affinity to MHC class I and adequate processing and presentation by malignant cells to trigger full activation of specific T cells. In silico prediction with three algorithms indicated 13 peptides of Cyclin A1 9 to 11 amino acids of length to have high affinity to HLA-A*02:01. Ten of them proved to be affine in an HLA stabilization assay using TAP-deficient T2 cells. Their immunogenicity was assessed by repetitive stimulation of CD8+ T cells from two healthy donors with single-peptide-pulsed dendritic cells or monocytes. Intracellular cytokine staining quantified the enrichment of peptide-specific functional T cells. Seven peptides were immunogenic, three of them against both donors. Specific cell lines were cloned and used in killing assays to demonstrate recognition of endogenous Cyclin A1 in the HLA-A*02:01-positive AML cell line THP-1. Immunopeptidome analysis based on direct isolation of HLA-presented peptides by mass spectrometry of primary AML and OC samples identified four naturally presented epitopes of Cyclin A1. The immunopeptidome of HeLa cells transfected with Cyclin A1 and HLA-A*02:01 revealed six Cyclin A1-derived HLA ligands. Epitope p410–420 showed high affinity to HLA-A*02:01 and immunogenicity in both donors. It proved to be naturally presented on primary AML blast and provoked spontaneous functional response of T cells from treatment naïve OC and, therefore, warrants further development for clinical application.
datePublished:2020-03-10T00:00:00Z
dateModified:2021-06-25T00:00:00Z
pageStart:1217
pageEnd:1227
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00262-020-02519-6
keywords:
Cyclin A1
Epitope
CD8 T cell
HLA immunopeptidome
Acute myeloid leukemia
Ovarian carcinoma
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02519-6/MediaObjects/262_2020_2519_Fig3_HTML.png
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:69
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Anja Tatjana Teck
url:http://orcid.org/0000-0002-9563-0341
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
type:Person
name:Sabrina Urban
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
type:Person
name:Petra Quass
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Annika Nelde
affiliation:
name:University of Tübingen
address:
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:University Hospital Tübingen
address:
name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:Heiko Schuster
affiliation:
name:University of Tübingen
address:
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:Immatics Biotechnologies GmbH
address:
name:Immatics Biotechnologies GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
type:Person
name:Anne Letsch
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Antonia Busse
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Juliane Sarah Walz
affiliation:
name:University of Tübingen
address:
name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Ulrich Keilholz
affiliation:
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
type:Person
name:Sebastian Ochsenreither
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:69
Organization:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:University of Tübingen
address:
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
type:PostalAddress
name:University Hospital Tübingen
address:
name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
type:PostalAddress
name:University of Tübingen
address:
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
type:PostalAddress
name:Immatics Biotechnologies GmbH
address:
name:Immatics Biotechnologies GmbH, Tübingen, Germany
type:PostalAddress
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:University of Tübingen
address:
name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Anja Tatjana Teck
url:http://orcid.org/0000-0002-9563-0341
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:Sabrina Urban
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:Petra Quass
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:Annika Nelde
affiliation:
name:University of Tübingen
address:
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:University Hospital Tübingen
address:
name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:Heiko Schuster
affiliation:
name:University of Tübingen
address:
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:Immatics Biotechnologies GmbH
address:
name:Immatics Biotechnologies GmbH, Tübingen, Germany
type:PostalAddress
type:Organization
name:Anne Letsch
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:Antonia Busse
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:Juliane Sarah Walz
affiliation:
name:University of Tübingen
address:
name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:Ulrich Keilholz
affiliation:
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
name:Sebastian Ochsenreither
affiliation:
name:Charité Berlin
address:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
type:PostalAddress
type:Organization
name:Charité Comprehensive Cancer Center
address:
name:Charité Comprehensive Cancer Center, Berlin, Germany
type:PostalAddress
type:Organization
name:German Cancer Research Center (DKFZ)
address:
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
name:Charité Comprehensive Cancer Center, Berlin, Germany
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
name:Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany
name:Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany
name:Immatics Biotechnologies GmbH, Tübingen, Germany
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Charité Comprehensive Cancer Center, Berlin, Germany
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
name:Department of Hematology and Oncology, Campus Benjamin Franklin, Charité Berlin, Berlin, Germany
name:Charité Comprehensive Cancer Center, Berlin, Germany
name:German Cancer Research Center (DKFZ), Heidelberg, Germany
External Links {🔗}(194)
- What's the monthly income of https://www.springernature.com/gp/authors?
- Discover the revenue of https://link.springernature.com/home/
- How much money does https://order.springer.com/public/cart make?
- What's the income generated by https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research each month?
- How much does https://submission.nature.com/new-submission/262/3 net monthly?
- https://orcid.org/0000-0002-9563-0341's total income per month
- How much does https://beta.springernature.com/pre-submission?journalId=262 earn?
- How much does https://doi.org/10.1007/s00262-021-02977-6 rake in every month?
- Learn how profitable https://doi.org/10.1186/s40425-018-0349-3 is on a monthly basis
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29769148's financial summary
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956851's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=Current%20landscape%20and%20future%20of%20dual%20anti-CTLA4%20and%20PD-1%2FPD-L1%20blockade%20immunotherapy%20in%20cancer%3B%20lessons%20learned%20from%20clinical%20trials%20with%20melanoma%20and%20non-small%20cell%20lung%20cancer%20%28NSCLC%29&journal=J%20Immunother%20Cancer&doi=10.1186%2Fs40425-018-0349-3&publication_year=2018&author=Chae%2CYK&author=Arya%2CA&author=Iams%2CW&author=Cruz%2CMR&author=Chandra%2CS&author=Choi%2CJ&author=Giles%2CF bring in each month?
- What's the income generated by https://doi.org/10.1126/science.aar4060 each month?
- How much income is https://doi.org/10.1126%2Fscience.aar4060 earning monthly?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29567705
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391259's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Cancer%20immunotherapy%20using%20checkpoint%20blockade&journal=Science&doi=10.1126%2Fscience.aar4060&volume=359&issue=6382&pages=1350-1355&publication_year=2018&author=Ribas%2CA&author=Wolchok%2CJD pull in?
- How much does https://doi.org/10.1056/NEJMoa1709919 make?
- How much profit does https://doi.org/10.1056%2FNEJMoa1709919 generate?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29385376 each month?
- How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637939 making per month?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Long-term%20follow-up%20of%20CD19%20CAR%20therapy%20in%20acute%20lymphoblastic%20leukemia&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1709919&volume=378&issue=5&pages=449-459&publication_year=2018&author=Park%2CJH&author=Riviere%2CI&author=Gonen%2CM&author=Wang%2CX&author=Senechal%2CB&author=Curran%2CKJ&author=Sauter%2CC&author=Wang%2CY&author=Santomasso%2CB&author=Mead%2CE&author=Roshal%2CM&author=Maslak%2CP&author=Davila%2CM&author=Brentjens%2CRJ&author=Sadelain%2CM?
- What's https://doi.org/10.1158/1078-0432.CCR-14-2708's gross income?
- Get to know what's the income of https://doi.org/10.1158%2F1078-0432.CCR-14-2708
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=A%20pilot%20trial%20using%20lymphocytes%20genetically%20engineered%20with%20an%20NY-ESO-1-reactive%20T-cell%20receptor%3A%20long-term%20follow-up%20and%20correlates%20with%20response&journal=Clin%20Cancer%20Res%3A%20Off%20J%20Am%20Assoc%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-2708&volume=21&issue=5&pages=1019-1027&publication_year=2015&author=Robbins%2CPF&author=Kassim%2CSH&author=Tran%2CTL&author=Crystal%2CJS&author=Morgan%2CRA&author=Feldman%2CSA&author=Yang%2CJC&author=Dudley%2CME&author=Wunderlich%2CJR&author=Sherry%2CRM&author=Kammula%2CUS&author=Hughes%2CMS&author=Restifo%2CNP&author=Raffeld%2CM&author=Lee%2CCC&author=Li%2CYF&author=El-Gamil%2CM&author=Rosenberg%2CSA
- https://doi.org/10.1200/JCO.2010.32.2537's revenue stream
- Monthly income for https://doi.org/10.1200%2FJCO.2010.32.2537
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor%20regression%20in%20patients%20with%20metastatic%20synovial%20cell%20sarcoma%20and%20melanoma%20using%20genetically%20engineered%20lymphocytes%20reactive%20with%20NY-ESO-1&journal=J%20Clin%20Oncol%3A%20Off%20J%20Am%20Soc%20Clin%20Oncol&doi=10.1200%2FJCO.2010.32.2537&volume=29&issue=7&pages=917-924&publication_year=2011&author=Robbins%2CPF&author=Morgan%2CRA&author=Feldman%2CSA&author=Yang%2CJC&author=Sherry%2CRM&author=Dudley%2CME&author=Wunderlich%2CJR&author=Nahvi%2CAV&author=Helman%2CLJ&author=Mackall%2CCL&author=Kammula%2CUS&author=Hughes%2CMS&author=Restifo%2CNP&author=Raffeld%2CM&author=Lee%2CCC&author=Levy%2CCL&author=Li%2CYF&author=El-Gamil%2CM&author=Schwarz%2CSL&author=Laurencot%2CC&author=Rosenberg%2CSA pull in monthly?
- What's the profit of https://doi.org/10.1158/1078-0432.CCR-15-0860?
- How much income does https://doi.org/10.1158%2F1078-0432.CCR-15-0860 have?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=New%20strategies%20in%20engineering%20t-cell%20receptor%20gene-modified%20t%20cells%20to%20more%20effectively%20target%20malignancies&journal=Clin%20Cancer%20Res%3A%20Off%20J%20Am%20Assoc%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-15-0860&volume=21&issue=23&pages=5191-5197&publication_year=2015&author=Schmitt%2CTM&author=Stromnes%2CIM&author=Chapuis%2CAG&author=Greenberg%2CPD is on a monthly basis
- How much does https://doi.org/10.1038/nbt.4004 pull in monthly?
- How profitable is https://doi.org/10.1038%2Fnbt.4004?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29106410
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722674's revenue stream
- Find out how much http://scholar.google.com/scholar_lookup?&title=Generation%20of%20higher%20affinity%20T%20cell%20receptors%20by%20antigen-driven%20differentiation%20of%20progenitor%20T%20cells%20in%20vitro&journal=Nat%20Biotechnol&doi=10.1038%2Fnbt.4004&volume=35&issue=12&pages=1188-1195&publication_year=2017&author=Schmitt%2CTM&author=Aggen%2CDH&author=Ishida-Tsubota%2CK&author=Ochsenreither%2CS&author=Kranz%2CDM&author=Greenberg%2CPD earns monthly
- Profit of https://doi.org/10.1089/hgtb.2014.004
- https://doi.org/10.1089%2Fhgtb.2014.004 income
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25143008?
- What's http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208561's gross income?
- How much does http://scholar.google.com/scholar_lookup?&title=Manufacture%20of%20gene-modified%20human%20T-cells%20with%20a%20memory%20stem%2Fcentral%20memory%20phenotype&journal=Hum%20Gene%20Ther%20Methods&doi=10.1089%2Fhgtb.2014.004&volume=25&issue=5&pages=277-287&publication_year=2014&author=Gomez-Eerland%2CR&author=Nuijen%2CB&author=Heemskerk%2CB&author=Rooij%2CN&author=Berg%2CJH&author=Beijnen%2CJH&author=Uckert%2CW&author=Kvistborg%2CP&author=Schumacher%2CTN&author=Haanen%2CJB&author=Jorritsma%2CA bring in each month?
- How much does https://doi.org/10.1172/JCI32103 pull in monthly?
- How much does https://doi.org/10.1172%2FJCI32103 generate monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18060041 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Adoptive%20transfer%20of%20effector%20CD8%2B%20T%20cells%20derived%20from%20central%20memory%20cells%20establishes%20persistent%20T%20cell%20memory%20in%20primates&journal=J%20Clin%20Investig&doi=10.1172%2FJCI32103&volume=118&issue=1&pages=294-305&publication_year=2008&author=Berger%2CC&author=Jensen%2CMC&author=Lansdorp%2CPM&author=Gough%2CM&author=Elliott%2CC&author=Riddell%2CSR generate monthly?
- What are the total earnings of https://doi.org/10.1158/1078-0432.CCR-17-1012?
- Check the income stats for https://doi.org/10.1158%2F1078-0432.CCR-17-1012
- Financial intake of http://scholar.google.com/scholar_lookup?&title=T-cell%20receptors%20for%20clinical%20therapy%3A%20in%20vitro%20assessment%20of%20toxicity%20risk&journal=Clin%20Cancer%20Res%3A%20Off%20J%20Am%20Assoc%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-17-1012&volume=23&issue=20&pages=6012-6020&publication_year=2017&author=Kunert%2CA&author=Obenaus%2CM&author=Lamers%2CCHJ&author=Blankenstein%2CT&author=Debets%2CR
- Check the income stats for https://doi.org/10.1182/blood-2011-07-365890
- How much money does https://doi.org/10.1182%2Fblood-2011-07-365890 generate?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22529286
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369684?
- How much does http://scholar.google.com/scholar_lookup?&title=Cyclin-A1%20represents%20a%20new%20immunogenic%20targetable%20antigen%20expressed%20in%20acute%20myeloid%20leukemia%20stem%20cells%20with%20characteristics%20of%20a%20cancer-testis%20antigen&journal=Blood&doi=10.1182%2Fblood-2011-07-365890&volume=119&issue=23&pages=5492-5501&publication_year=2012&author=Ochsenreither%2CS&author=Majeti%2CR&author=Schmitt%2CT&author=Stirewalt%2CD&author=Keilholz%2CU&author=Loeb%2CKR&author=Wood%2CB&author=Choi%2CYE&author=Bleakley%2CM&author=Warren%2CEH&author=Hudecek%2CM&author=Akatsuka%2CY&author=Weissman%2CIL&author=Greenberg%2CPD pull in?
- How much does https://doi.org/10.3324/haematol.2012.065581 earn?
- Explore the financials of https://doi.org/10.3324%2Fhaematol.2012.065581
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22532518?
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487554
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=RHAMM%2FHMMR%20%28CD168%29%20is%20not%20an%20ideal%20target%20antigen%20for%20immunotherapy%20of%20acute%20myeloid%20leukemia&journal=Haematologica&doi=10.3324%2Fhaematol.2012.065581&volume=97&issue=10&pages=1539-1547&publication_year=2012&author=Snauwaert%2CS&author=Vanhee%2CS&author=Goetgeluk%2CG&author=Verstichel%2CG&author=Caeneghem%2CY&author=Velghe%2CI&author=Philippe%2CJ&author=Berneman%2CZN&author=Plum%2CJ&author=Taghon%2CT&author=Leclercq%2CG&author=Thielemans%2CK&author=Kerre%2CT&author=Vandekerckhove%2CB?
- How much does https://doi.org/10.1007/s00401-018-1836-9 pull in monthly?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29557506?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=The%20natural%20HLA%20ligandome%20of%20glioblastoma%20stem-like%20cells%3A%20antigen%20discovery%20for%20T%20cell-based%20immunotherapy&journal=Acta%20Neuropathol&doi=10.1007%2Fs00401-018-1836-9&volume=135&issue=6&pages=923-938&publication_year=2018&author=Neidert%2CMC&author=Kowalewski%2CDJ&author=Silginer%2CM&author=Kapolou%2CK&author=Backert%2CL&author=Freudenmann%2CLK&author=Peper%2CJK&author=Marcu%2CA&author=Wang%2CSS&author=Walz%2CJS&author=Wolpert%2CF&author=Rammensee%2CHG&author=Henschler%2CR&author=Lamszus%2CK&author=Westphal%2CM&author=Roth%2CP&author=Regli%2CL&author=Stevanovic%2CS&author=Weller%2CM&author=Eisele%2CG?
- How much does https://doi.org/10.1007/s00018-011-0658-x earn?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21387143?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Insights%20into%20the%20processing%20of%20MHC%20class%20I%20ligands%20gained%20from%20the%20study%20of%20human%20tumor%20epitopes&journal=Cell%20Mol%20Life%20Sci%3ACMLS&doi=10.1007%2Fs00018-011-0658-x&volume=68&issue=9&pages=1503-1520&publication_year=2011&author=Vigneron%2CN&author=Eynde%2CBJ each month?
- How much does https://doi.org/10.1186/s12885-015-1824-6 earn?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26499264 bring in?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619521 gross monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Cancer-testis%20antigen%20cyclin%20A1%20is%20broadly%20expressed%20in%20ovarian%20cancer%20and%20is%20associated%20with%20prolonged%20time%20to%20tumor%20progression%20after%20platinum-based%20therapy&journal=BMC%20Cancer&doi=10.1186%2Fs12885-015-1824-6&volume=15&publication_year=2015&author=Arsenic%2CR&author=Braicu%2CEI&author=Letsch%2CA&author=Dietel%2CM&author=Sehouli%2CJ&author=Keilholz%2CU&author=Ochsenreither%2CS?
- Get to know what's the income of https://doi.org/10.1007/978-3-642-19065-0_17
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21630154?
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080912?
- Get to know http://scholar.google.com/scholar_lookup?&title=Function%20of%20the%20A-type%20cyclins%20during%20gametogenesis%20and%20early%20embryogenesis&journal=Results%20Probl%20Cell%20Differ&doi=10.1007%2F978-3-642-19065-0_17&volume=53&pages=391-413&publication_year=2011&author=Wolgemuth%2CDJ's earnings
- How much money does http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20a%20second%20human%20Cyclin%20A%20that%20is%20highly%20expressed%20in%20testis%20and%20in%20several%20leukemic%20cell%20lines&journal=Can%20Res&volume=57&issue=5&pages=913-920&publication_year=1997&author=Yang%2CR&author=Morosetti%2CR&author=Koeffler%2CHP make?
- How much does https://doi.org/10.1073/pnas.121540098 pull in?
- How much cash flow does https://doi.org/10.1073%2Fpnas.121540098 have monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11381140 generate?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC34442 earn?
- How much money does http://scholar.google.com/scholar_lookup?&title=Altered%20myelopoiesis%20and%20the%20development%20of%20acute%20myeloid%20leukemia%20in%20transgenic%20mice%20overexpressing%20Cyclin%20A1&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.121540098&volume=98&issue=12&pages=6853-6858&publication_year=2001&author=Liao%2CC&author=Wang%2CXY&author=Wei%2CHQ&author=Li%2CSQ&author=Merghoub%2CT&author=Pandolfi%2CPP&author=Wolgemuth%2CDJ generate?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8254189 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Scheme%20for%20ranking%20potential%20HLA-A2%20binding%20peptides%20based%20on%20independent%20binding%20of%20individual%20peptide%20side-chains&journal=J%20Immunol&volume=152&issue=1&pages=163-175&publication_year=1994&author=Parker%2CKC&author=Bednarek%2CMA&author=Coligan%2CJE bring in each month?
- What are the earnings of https://doi.org/10.1093/nar/gks438?
- What is the earnings of https://doi.org/10.1093%2Fnar%2Fgks438?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22610854 generate?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394288 have monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Immune%20epitope%20database%20analysis%20resource&journal=Nucl%20Acids%20Res&doi=10.1093%2Fnar%2Fgks438&volume=40&issue=Web%20Server%20issue&pages=W525-W530&publication_year=2012&author=Kim%2CY&author=Ponomarenko%2CJ&author=Zhu%2CZ&author=Tamang%2CD&author=Wang%2CP&author=Greenbaum%2CJ&author=Lundegaard%2CC&author=Sette%2CA&author=Lund%2CO&author=Bourne%2CPE&author=Nielsen%2CM&author=Peters%2CB pull in?
- Get to know https://doi.org/10.1007/s002510050595's earnings
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10602881 making per month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=SYFPEITHI%3A%20database%20for%20MHC%20ligands%20and%20peptide%20motifs&journal=Immunogenetics&doi=10.1007%2Fs002510050595&volume=50&issue=3%E2%80%934&pages=213-219&publication_year=1999&author=Rammensee%2CHG&author=Bachmann%2CJ&author=Emmerich%2CNPN&author=Bachor%2COA&author=Stevanovic%2CS?
- How much money does https://doi.org/10.1038/leu.2014.233 make?
- How much revenue does https://doi.org/10.1038%2Fleu.2014.233 produce monthly?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25092142's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Mapping%20the%20HLA%20ligandome%20landscape%20of%20acute%20myeloid%20leukemia%3A%20a%20targeted%20approach%20toward%20peptide-based%20immunotherapy&journal=Leukemia&doi=10.1038%2Fleu.2014.233&volume=29&issue=3&pages=647-659&publication_year=2015&author=Berlin%2CC&author=Kowalewski%2CDJ&author=Schuster%2CH&author=Mirza%2CN&author=Walz%2CS&author=Handel%2CM&author=Schmid-Horch%2CB&author=Salih%2CHR&author=Kanz%2CL&author=Rammensee%2CHG&author=Stevanovic%2CS&author=Stickel%2CJS pull in?
- Earnings of https://doi.org/10.1007/978-1-62703-218-6_12
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23329485 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Biochemical%20large-scale%20identification%20of%20MHC%20class%20I%20ligands&journal=Methods%20Mol%20Biol&doi=10.1007%2F978-1-62703-218-6_12&volume=960&pages=145-157&publication_year=2013&author=Kowalewski%2CDJ&author=Stevanovic%2CS pull in monthly?
- How much money does https://doi.org/10.1073/pnas.1416389112 make?
- See how much https://doi.org/10.1073%2Fpnas.1416389112 makes per month
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25548167?
- How profitable is http://scholar.google.com/scholar_lookup?&title=HLA%20ligandome%20analysis%20identifies%20the%20underlying%20specificities%20of%20spontaneous%20antileukemia%20immune%20responses%20in%20chronic%20lymphocytic%20leukemia%20%28CLL%29&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1416389112&volume=112&issue=2&pages=E166-175&publication_year=2015&author=Kowalewski%2CDJ&author=Schuster%2CH&author=Backert%2CL&author=Berlin%2CC&author=Kahn%2CS&author=Kanz%2CL&author=Salih%2CHR&author=Rammensee%2CHG&author=Stevanovic%2CS&author=Stickel%2CJS?
- Learn about the earnings of https://doi.org/10.1080/2162402X.2017.1316438
- Find out how much https://doi.org/10.1080%2F2162402X.2017.1316438 earns monthly
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29632711 make?
- How much income is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889201 earning monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=HLA%20ligandome%20analysis%20of%20primary%20chronic%20lymphocytic%20leukemia%20%28CLL%29%20cells%20under%20lenalidomide%20treatment%20confirms%20the%20suitability%20of%20lenalidomide%20for%20combination%20with%20T-cell-based%20immunotherapy&journal=Oncoimmunology&doi=10.1080%2F2162402X.2017.1316438&volume=7&issue=4&publication_year=2018&author=Nelde%2CA&author=Kowalewski%2CDJ&author=Backert%2CL&author=Schuster%2CH&author=Werner%2CJO&author=Klein%2CR&author=Kohlbacher%2CO&author=Kanz%2CL&author=Salih%2CHR&author=Rammensee%2CHG&author=Stevanovic%2CS&author=Walz%2CJS generate?
- Learn about the earnings of https://doi.org/10.1016/1044-0305(94)80016-2
- How much does https://doi.org/10.1016%2F1044-0305%2894%2980016-2 make?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24226387
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=An%20approach%20to%20correlate%20tandem%20mass%20spectral%20data%20of%20peptides%20with%20amino%20acid%20sequences%20in%20a%20protein%20database&journal=J%20Am%20Soc%20Mass%20Spectrom&doi=10.1016%2F1044-0305%2894%2980016-2&volume=5&issue=11&pages=976-989&publication_year=1994&author=Eng%2CJK&author=McCormack%2CAL&author=Yates%2CJR?
- How much money does https://doi.org/10.1038/nmeth1113 generate?
- What's the financial gain of https://doi.org/10.1038%2Fnmeth1113?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17952086's gross income?
- How much does http://scholar.google.com/scholar_lookup?&title=Semi-supervised%20learning%20for%20peptide%20identification%20from%20shotgun%20proteomics%20datasets&journal=Nat%20Methods&doi=10.1038%2Fnmeth1113&volume=4&issue=11&pages=923-925&publication_year=2007&author=Kall%2CL&author=Canterbury%2CJD&author=Weston%2CJ&author=Noble%2CWS&author=MacCoss%2CMJ pull in monthly?
- https://doi.org/10.1186/s13073-016-0288-x's revenue stream
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27029192
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812631?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=NetMHCpan-3.0%3B%20improved%20prediction%20of%20binding%20to%20MHC%20class%20I%20molecules%20integrating%20information%20from%20multiple%20receptor%20and%20peptide%20length%20datasets&journal=Genome%20Med&doi=10.1186%2Fs13073-016-0288-x&volume=8&issue=1&publication_year=2016&author=Nielsen%2CM&author=Andreatta%2CM?
- Revenue of https://doi.org/10.1016/j.jim.2005.11.023
- What is the monthly revenue of https://doi.org/10.1016%2Fj.jim.2005.11.023?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16469329 generate?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=In%20vitro%20methods%20for%20generating%20CD8%2B%20T-cell%20clones%20for%20immunotherapy%20from%20the%20naive%20repertoire&journal=J%20Immunol%20Methods&doi=10.1016%2Fj.jim.2005.11.023&volume=310&issue=1%E2%80%932&pages=40-52&publication_year=2006&author=Ho%2CWY&author=Nguyen%2CHN&author=Wolfl%2CM&author=Kuball%2CJ&author=Greenberg%2CPD bring in?
- What is the earnings of https://doi.org/10.1016/j.jim.2010.06.005?
- How much revenue does https://doi.org/10.1016%2Fj.jim.2010.06.005 produce monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20558172 generate?
- http://scholar.google.com/scholar_lookup?&title=A%20flow%20cytometry-based%20assay%20to%20assess%20minute%20frequencies%20of%20CD8%2B%20T%20cells%20by%20their%20cytolytic%20function&journal=J%20Immunol%20Methods&doi=10.1016%2Fj.jim.2010.06.005&volume=360&issue=1%E2%80%932&pages=56-65&publication_year=2010&author=Stanke%2CJ&author=Hoffmann%2CC&author=Erben%2CU&author=Keyserling%2CH&author=Stevanovic%2CS&author=Cichon%2CG&author=Schneider%2CA&author=Kaufmann%2CAM's revenue stream
- What's the income of https://doi.org/10.1158/2326-6066.CIR-15-0042?
- What's the monthly money flow for https://doi.org/10.1158%2F2326-6066.CIR-15-0042?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25847967
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391277 bring in each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=alphabeta%20TCR-mediated%20recognition%3A%20relevance%20to%20tumor-antigen%20discovery%20and%20cancer%20immunotherapy&journal=Cancer%20Immunol%20Res&doi=10.1158%2F2326-6066.CIR-15-0042&volume=3&issue=4&pages=305-312&publication_year=2015&author=Reinherz%2CEL generate?
- Profit of https://doi.org/10.1128/JVI.03664-13
- How much does https://doi.org/10.1128%2FJVI.03664-13 pull in?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24554667's gross income?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019089 pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=Boosting%20functional%20avidity%20of%20CD8%2B%20T%20cells%20by%20vaccinia%20virus%20vaccination%20depends%20on%20intrinsic%20T-cell%20MyD88%20expression%20but%20not%20the%20inflammatory%20milieu&journal=J%20Virol&doi=10.1128%2FJVI.03664-13&volume=88&issue=10&pages=5356-5368&publication_year=2014&author=Hu%2CZ&author=Wang%2CJ&author=Wan%2CY&author=Zhu%2CL&author=Ren%2CX&author=Qiu%2CS&author=Ren%2CY&author=Yuan%2CS&author=Ding%2CX&author=Chen%2CJ&author=Qiu%2CC&author=Sun%2CJ&author=Zhang%2CX&author=Xiang%2CJ&author=Qiu%2CC&author=Xu%2CJ pull in?
- How much revenue does https://doi.org/10.1016/j.ccr.2013.03.018 produce monthly?
- How much does https://doi.org/10.1016%2Fj.ccr.2013.03.018 make?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23597565 make?
- What is the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658176?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Relapse%20or%20eradication%20of%20cancer%20is%20predicted%20by%20peptide-major%20histocompatibility%20complex%20affinity&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2013.03.018&volume=23&issue=4&pages=516-526&publication_year=2013&author=Engels%2CB&author=Engelhard%2CVH&author=Sidney%2CJ&author=Sette%2CA&author=Binder%2CDC&author=Liu%2CRB&author=Kranz%2CDM&author=Meredith%2CSC&author=Rowley%2CDA&author=Schreiber%2CH?
- How much money does https://doi.org/10.1128/JVI.00093-11 make?
- Monthly income for https://doi.org/10.1128%2FJVI.00093-11
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21367907 make?
- What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126217?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Immunodominance%20of%20HLA-A2-restricted%20hepatitis%20C%20virus-specific%20CD8%2B%20T%20cell%20responses%20is%20linked%20to%20naive-precursor%20frequency&journal=J%20Virol&doi=10.1128%2FJVI.00093-11&volume=85&issue=10&pages=5232-5236&publication_year=2011&author=Schmidt%2CJ&author=Neumann-Haefelin%2CC&author=Altay%2CT&author=Gostick%2CE&author=Price%2CDA&author=Lohmann%2CV&author=Blum%2CHE&author=Thimme%2CR?
- How much profit is https://doi.org/10.1007/s00262-011-1099-y making per month?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21898091's financial summary
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Wilms%27%20tumor%20protein%201%20%28WT1%29%20peptide%20vaccination%20in%20AML%20patients%3A%20predominant%20TCR%20CDR3beta%20sequence%20associated%20with%20remission%20in%20one%20patient%20is%20detectable%20in%20other%20vaccinated%20patients&journal=Cancer%20Immunol%20Immunother%3A%20CII&doi=10.1007%2Fs00262-011-1099-y&volume=61&issue=3&pages=313-322&publication_year=2012&author=Ochsenreither%2CS&author=Fusi%2CA&author=Geikowski%2CA&author=Stather%2CD&author=Busse%2CA&author=Stroux%2CA&author=Letsch%2CA&author=Keilholz%2CU
- How much does https://doi.org/10.1182%2Fblood.V128.22.914.914 make?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Endogenous%20immunoglobulin-derived%20neoepitopes%20are%20processed%20and%20form%20a%20sizeable%20fraction%20of%20the%20HLA%20class%20I%20ligandome%20of%20human%20lymphoma%20cells&journal=Blood&doi=10.1182%2Fblood.V128.22.914.914&volume=128&issue=22&publication_year=2016&author=Bergen%2CCAM&author=Steen%2CDM&author=Kester%2CMGD&author=Koning%2CMT&author=Veelen%2CPA&author=Griffioen%2CM&author=Falkenburg%2CJHF&author=Heemskerk%2CMHM&author=Veelken%2CH&author=Navarrete%2CMA?
- What's the financial intake of https://doi.org/10.1182/blood-2015-04-640532?
- How much does https://doi.org/10.1182%2Fblood-2015-04-640532 pull in?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26138685
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608392 bring in?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=The%20antigenic%20landscape%20of%20multiple%20myeloma%3A%20mass%20spectrometry%20%28re%29defines%20targets%20for%20T-cell-based%20immunotherapy&journal=Blood&doi=10.1182%2Fblood-2015-04-640532&volume=126&issue=10&pages=1203-1213&publication_year=2015&author=Walz%2CS&author=Stickel%2CJS&author=Kowalewski%2CDJ&author=Schuster%2CH&author=Weisel%2CK&author=Backert%2CL&author=Kahn%2CS&author=Nelde%2CA&author=Stroh%2CT&author=Handel%2CM&author=Kohlbacher%2CO&author=Kanz%2CL&author=Salih%2CHR&author=Rammensee%2CHG&author=Stevanovic%2CS
- Find out how much https://citation-needed.springer.com/v2/references/10.1007/s00262-020-02519-6?format=refman&flavour=references earns monthly
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anja%20Tatjana%20Teck produce monthly?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anja%20Tatjana%20Teck%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sabrina%20Urban?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sabrina%20Urban%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Petra%20Quass pull in monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Petra%20Quass%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Annika%20Nelde each month?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Annika%20Nelde%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Heiko%20Schuster have monthly?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Heiko%20Schuster%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anne%20Letsch
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anne%20Letsch%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Antonia%20Busse?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Antonia%20Busse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Juliane%20Sarah%20Walz earning monthly?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Juliane%20Sarah%20Walz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ulrich%20Keilholz?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ulrich%20Keilholz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sebastian%20Ochsenreither's gross income?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sebastian%20Ochsenreither%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income generated by http://creativecommons.org/licenses/by/4.0/ each month?
- Get to know https://s100.copyright.com/AppDispatchServlet?title=Cancer%20testis%20antigen%20Cyclin%20A1%20harbors%20several%20HLA-A%2A02%3A01-restricted%20T%20cell%20epitopes%2C%20which%20are%20presented%20and%20recognized%20in%20vivo&author=Anja%20Tatjana%20Teck%20et%20al&contentID=10.1007%2Fs00262-020-02519-6©right=The%20Author%28s%29&publication=0340-7004&publicationDate=2020-03-10&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY's earnings
- How much does https://crossmark.crossref.org/dialog/?doi=10.1007/s00262-020-02519-6 make?
- What's the financial outcome of https://citation-needed.springer.com/v2/references/10.1007/s00262-020-02519-6?format=refman&flavour=citation?
- https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's financial summary
- Monthly income for https://www.springernature.com/gp/products
- Profit of https://www.springernature.com/gp/librarians
- What is the earnings of https://www.springernature.com/gp/societies?
- How much money does https://www.springernature.com/gp/partners generate?
- How much revenue does https://www.springer.com/ produce monthly?
- What's the financial gain of https://www.nature.com/?
- What's https://www.biomedcentral.com/'s gross income?
- What's the monthly income of https://www.palgrave.com/?
- See how much https://www.apress.com/ makes per month
- How much does https://www.springernature.com/gp/legal/ccpa pull in monthly?
- What's the total monthly financial gain of https://www.springernature.com/gp/info/accessibility?
- What's the financial outcome of https://support.springernature.com/en/support/home?
- What's the monthly income of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- What's the financial gain of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref